Do Cardiovascular Risk Factors Influence Cardiac Allograft Vasculopathy?

Transplantation Proceedings - Tập 38 - Trang 2572-2574 - 2006
C.I. Chamorro1, L. Almenar1, L. Martı́nez-Dolz1, E. Sánchez-Lacuesta1, J. Martı́n-Pastor1, F. Ten-Morro1, R.M. Sánchez-Soriano1, J. Agüero1, V. Ortiz1, J.A. Moro1, A. Salvador1
1Cardiac Failure and Transplant Unit, La Fe University Hospital, Valencia, Spain

Tài liệu tham khảo

Kobashigawa, 2000, What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?, Curr Control Trials Cardiovasc Med, 1, 166, 10.1186/CVM-1-3-166 Labarrere, 1999, Relationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation, Curr Opin Cardiol, 14, 133, 10.1097/00001573-199903000-00010 Kapadia, 2000, Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging, J Heart Lung Transplant, 19, 167, 10.1016/S1053-2498(99)00128-X Tuzcu, 2005, Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation, J Am Coll Cardiol, 45, 1538, 10.1016/j.jacc.2004.12.076 Billingham, 1992, Histopathology of graft coronary disease, J Heart Lung Transplant, 11, S38 Lindenfeld, 2005, Drug therapy in the heart transplant recipient: Part III: common medical problems, Circulation, 111, 113, 10.1161/01.CIR.0000151609.60618.3C Rickenbacher, 1996, Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors, Transplantation, 61, 46, 10.1097/00007890-199601150-00011 Eisen, 2003, Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients, N Engl J Med, 349, 847, 10.1056/NEJMoa022171